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ABSTRACT
Objectives: The main objectives of this work were to estimate the frequency, type, and nature of possible drug–drug interactions in prescriptions 
dispensed from community pharmacies in Al-Najaf city, secondary objectives were the study of the association between specialty of physicians and 
the rate of recurrence of drug–drug interactions and to determine medication classes, which were involved in possible drug–drug interactions.
Methods: To investigate this study, 211 prescriptions dispensed in three community pharmacies in Al-Najaf city were collected and by the 
computerized screening program to identify drug–drug interactions.
Results: The results showed that the total number of interactions was recognized to be 41% of all prescriptions with the prevalence of major drug–
drug interactions was 14%, minor was 16%, and moderate was 70%.
Conclusions: This study concluded that most identified drug–drug interactions were recognized in prescriptions written by an internal medicine 
specialist, orthopedics, general practitioners, an ear-nose-throat specialist, and general surgeon. The ratio of drug–drug interactions/number of 
prescriptions increased with increasing the number of drugs prescribed per patient (r=0.93, regression p<0.05). This study suggested that the role of 
the pharmacist should be moved from medication-oriented to patient-oriented, and the clinical pharmacists should have a vital function in recognizing 
and avoiding drug–drug interactions in prescriptions dispensed to patients.
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INTRODUCTION
Drug–drug interactions lead to a change of the action of one or more 
simultaneously administered drugs and that interactions classified as 
pharmacodynamic or pharmacokinetic, and may affect the effectiveness 
of medication [1]. Many drug–drug interactions, there was only a small 
part “clinically” significant [2]. Polypharmacy has been related to the 
occurrence of drug–drug interactions, medication errors, and adverse 
drug reactions [3,4]. Several researches recommend that drug–drug 
interactions may be the reason of about 3% of all hospital admittances [5]. 
Clinical pharmacists play an important role in protecting the patients 
from the hazards of potential drug–drug interactions, mainly with 
medications with a narrow therapeutic index [6,7].
Manual evaluation of drugs in a prescription can be completed by clinical 
pharmacists, but the efficacy in the finding of drug–drug interactions is 
about 50% in a two-drug prescription, and the percentage decreases 
significantly as the number of drugs increases [8]. Using the electronic 
drug–drug interactions screening databases, we can considerably 
increase the finding of the potential dangers of that interaction, beyond 
what can be completed with manual evaluation alone [9].
The aims of this work were to estimate the frequency, type, and nature 
of possible drug–drug interactions in prescriptions dispensed from 
community pharmacies in Al-Najaf city, secondary objectives were the 
studies of the association between specialty of physicians and the rate 
of recurrence of drug–drug interactions and to determine medication 
classes, which were involved in possible drug–drug interactions.
METHODS
Three-community pharmacy was selected randomly in Al-Najaf city 
to obtain a prescription from different physician specialty. All 1015 
dispensed medications in 211 prescriptions were collected during 
a 5 months. The data that we collected from the prescriptions were 
included: Age, gender, date of the prescription, diagnosis (if present), 
specialty of the prescribing physicians, name of the medications in 
each prescription, dosage, and quantity of medications dispensed. 
The possibility of drug–drug interactions was identified using the 
drug interactions checker [10]. Furthermore, the identified drug–drug 
interactions were categorized as major and moderate, depending on 
the severity of clinical importance.
For statistical analysis, IBM-SPSS statistics 24 was used. Pearson’s 
correlation coefficient considered to test the correlation (effects were 
considering statistical significant as p<0.05).
RESULTS
A total of (1015) drugs were prescribed to 211 prescriptions dispensed 
(Table 1). The average number of medications per patient was found 
to be 4.5±2.29 (range=1–8). Of the 211 prescriptions one had only one 
drug and the remaining (210) prescriptions had two or more drugs. 
Prescriptions with two or more drugs were checked for identified 
drug–drug interactions electronically using the drug interactions 
checker within www.drugs.com and classified as major and moderate 
according to their level of clinical importance.
The total number of interactions was recognized to be 86 of all 
prescriptions. Of these 86 drug–drug interactions, 12 were majors, 60 
were moderates, and 14 were minor (Fig. 1). Of the 12 major drug–drug 
interactions, seven cases involved pharmacokinetic interaction and 
five cases involved pharmacodynamics interaction. Major drug–drug 
interactions were recognized in prescriptions of patients with chronic 
illnesses. The most common diagnosis was found to be specialty 
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chronic respiratory disease (3) and coronary heart disease (6) and one 
was rheumatoid arthritis.
The greater ratio of moderate and minor was founded in 
orthopedics (25%), general practitioners (16,67%), ear-nose-throat 
(ENT) specialist (8.34%), and general surgeon (8.34). As show in Fig. 2 
the ratio of drug–drug interactions/number of prescriptions increased 
with increasing the number of drugs prescribed per patient. Finally, 
the ratio of drug–drug interactions per the number of prescriptions 
increased significantly with increase the number of drugs prescribed 
per patient (r=0.93, regression p<0.05).
DISCUSSION
The current research showed that the overall frequency of identified 
drug–drug interactions in prescriptions dispensed in community 
pharmacies in Al-Najaf city was 40.95%. The potential drug–drug 
interactions were classified depending on their severity, as major 
(dangerous interaction and need medical interferences to decrease 
or avoid severe toxic effects) and moderate (the interaction may 
increase the patient’s illness and/or need a change in medications). 
The prevalence of the major drug–drug interactions was 5.71% of 
all prescriptions dispensed, while the prevalence of the moderate 
drug–drug interactions was 35.24% of all prescriptions dispensed.
When comparing the prevalence of the major drug-drug interactions in 
the current study to the prevalence of the major drug-drug interactions 
in other studies which done in Greece [11] and Iran [12], we found that 
they recognized that 13.7% and 10.8% had major potential major drug-
drug interactions respectively.
The prevalence of the major drug–drug interactions increases in the 
elderly (at least 60 years old) as identified by Brazilian study done 
between November 2010 and April 2011 the data from 12,343 elderly 
patients, which showed a 33.3% prevalence of major potential drug–
drug interactions [13]. Our results evidently display that the ratio of 
potential drug–drug interactions/number of prescriptions is directly 
proportional to the number of medications prescribed per patient, 
in agreement with the outcomes of preceding researches [14]. Most 
identified drug–drug interactions were recognized in prescriptions 
written by internal medicine specialist, orthopedics, general 
practitioners, ENT specialist, and general surgeon and these physicians 
commonly written a greater number of drugs per prescription than 
others.
In the current study, the most common major drug–drug interactions 
were between ciprofloxacin antibiotic with other medication such 
as using citalopram together with ciprofloxacin can increase the risk 
of an irregular heart rhythm that may be serious and potentially 
life threatening. Some specific medications were intensely related 
with clinical drug–drug interactions such as amitriptyline, which 
interacted with a must of the common cold and flu medications 
including acetaminophen, chlorpheniramine, dextromethorphan, and 
phenylephrine [15].
The results showed that there is a problem of drug–drug interactions 
in prescriptions dispensed in community pharmacies in Al-Najaf 
city and establish the necessity for the routine usage of an enhanced 
dependable computerized screening system for drug–drug interactions. 
At present, many Al-Najaf pharmacies are equipped with a computer 
program for dispensing the drug, and therefore adding a drug-drug 
interaction screening system to that software appears possible in the 
near future. Greater researches with more hospital or community 
may provide more results that are dependable [16]. The routine uses 
of computerized prescriptions by physicians, bar codes to help in the 
identification of patients and their drugs, the application of a perfect 
system providing new scientific substantiation, as well as good choice 
of drug, are some of the recommendations strongly suggested currently 
to physicians [17]. Moreover, clinical pharmacists have a vital function 
in recognizing and avoiding drug–drug interactions in prescriptions 
dispensed to patients [18].
To develop an investigation of drug–drug interactions, numerous 
computerize screening software which identifies about drug–drug 
interactions have been established and assessed [19]. Often there are 
incompatible data between the several medications interaction because 
the organization of the severity of drug–drug interactions is not all 
the time straight forward. Therefore, the application of computerize 
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Fig. 2: The Pearson’s correlation coefficient between the number 
of medication per prescription and number of drug–drug 
interaction




1 2 3 4 5 6 7 8
Interaction 0 1 5 5 8 6 10 8
#of prescription 1 10 16 20 17 13 11 9
Sum 1 20 48 80 85 78 77 72
Age (mean±SD) 54.3±6.2
Gender Female
Interaction 0 2 4 7 5 9 7 9
#of prescription 0 12 17 24 20 16 13 12
Sum 0 24 51 96 100 96 91 96
Age (mean±SD) 48.6±8
Total drugs of 
male and female
1 44 99 176 185 174 168 168
SD: Standard deviation
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at hospital and community pharmacies has not removed the need 
for clinical pharmacists to have a hard understanding of drug–drug 
interactions.
CONCLUSIONS
The result of this study is that prescriptions dispensed in community 
pharmacies in Al-Najaf city shown a great incidence of drug–drug 
interactions in prescribed drugs. In particular, patients on multiple 
medications for respiratory disease and coronary diseases and patients 
receiving antidepressant, antibiotics, and common cold medications 
should be carefully observed for adverse results from drug–drug 
interactions. Recognizing and avoiding dangerous major drug–drug 
interaction is a critical factor of a clinical pharmacist’s job, and the 
role of the pharmacist should be moved from medication-oriented to 
patient-oriented. Physician’s especially internal medicine specialist, 
orthopedics, general practitioners, ENT specialist, general surgeon, and 
pharmacists must stay alert in their checking of drug–drug interactions 
and create suitable prescription modifications. The application of a 
computerize screening system to identified drug-drug interaction, 
which would provide pharmacists with the correct data to evaluate the 
degree of hazard to the patient and to avoid an adverse effect due to 
exposure to the interacting medications.
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